HeartSciences Inc.
HSCSNasdaqCIK 1468492FinancialsFiscal year ends Apr 30
Reports and events: 136 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2321:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-26-112224 |
| 2026-10-0616:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-107238 |
| 2026-10-0217:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-26-106500 |
| 2026-09-1708:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-100752 |
| 2026-09-1517:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-100185 |
| 2026-09-1416:14 ET | 10-Q | Quarterly reportPeriod 2026-07-31 | 0001437749-26-030319 |
| 2026-08-2007:43 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-091893 |
| 2026-08-1917:11 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001213900-26-091764 |
| 2026-08-1916:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-091720 |
| 2026-08-1820:13 ET | SCHEDULE 13D | Ownership report, active investor | 0001213900-26-091367 |
| 2026-08-1817:13 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-091301 |
| 2026-08-0717:00 ET | 8-K | 3.01 Delisting notice | 0001213900-26-086773 |
| 2026-07-2909:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-082577 |
| 2026-07-2716:30 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001213900-26-081833 |
| 2026-07-2716:26 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-081825 |
| 2026-07-2317:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-081007 |
| 2026-07-2316:48 ET | 10-K | Annual reportPeriod 2026-04-30 | 0001437749-26-024337 |
| 2026-07-1017:00 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-077218 |
| 2026-06-2617:22 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-072722 |
| 2026-06-2317:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-071186 |
| 2026-06-2308:33 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-070862 |
| 2026-05-0617:00 ET | 8-K | 5.07 Shareholder vote results | 0001213900-26-052872 |
| 2026-04-0317:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-26-040032 |
| 2026-03-1716:16 ET | DEF 14A | Proxy statementPeriod 2026-04-30 | 0001213900-26-029099 |
| 2026-03-1616:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-008420 |
| 2026-03-1616:04 ET | 10-Q | Quarterly reportPeriod 2026-01-31 | 0001437749-26-008399 |
| 2026-01-1617:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-005245 |
| 2025-12-1616:34 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-320983 |
| 2025-12-1516:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-319234 |
| 2025-12-1516:11 ET | 10-Q | Quarterly reportPeriod 2025-10-31 | 0001193125-25-319203 |
| 2025-11-2817:10 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-116128 |
| 2025-10-0117:23 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-227023 |
| 2025-09-1716:47 ET | 8-K | 3.01 Delisting notice | 0001193125-25-206295 |
| 2025-09-1116:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001468492-25-000011 |
| 2025-09-1116:04 ET | 10-Q | Quarterly reportPeriod 2025-07-31 | 0001468492-25-000010 |
| 2025-09-0819:19 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001468492-25-000006 |
| 2025-08-2216:09 ET | 8-K | 8.01 Other events | 0001468492-25-000003 |
| 2025-08-0408:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-070889 |
| 2025-07-3016:39 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-100335 |
| 2025-07-2416:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-098346 |
| 2025-07-2416:05 ET | 10-K | Annual reportPeriod 2025-04-30 | 0000950170-25-098326 |
| 2025-07-2116:56 ET | 8-K | 8.01 Other events | 0000950170-25-097293 |
| 2025-07-1409:00 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-063491 |
| 2025-07-0117:15 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-25-060467 |
| 2025-06-0409:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-081410 |
| 2025-06-0418:30 ET | 8-K | 1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-25-081197 |
| 2025-06-0309:00 ET | 8-K | 8.01 Other events | 0000950170-25-080578 |
| 2025-05-2816:51 ET | 8-K | 5.03 Amendment to articles or bylaws | 0000950170-25-078404 |
| 2025-05-1917:29 ET | 8-K | 3.01 Delisting notice; 8.01 Other events | 0000950170-25-074598 |
| 2025-03-2117:15 ET | 8-K | 3.01 Delisting notice | 0001013762-25-001087 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 17:13 ET. Listed shows no prices and gives no investment advice.